{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:28:25Z","timestamp":1765700905914},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/nrrheum.2012.216","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T09:11:40Z","timestamp":1355217100000},"page":"9-11","source":"Crossref","is-referenced-by-count":12,"title":["New ACR guidelines for gout management hold some surprises"],"prefix":"10.1038","volume":"9","author":[{"given":"Thomas","family":"Bardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"BFnrrheum2012216_CR1","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"71","author":"M Doherty","year":"2012","unstructured":"Doherty, M.  et al. Gout: why is this curable disease so seldom cured? Ann. Rheum. Dis. 71, 1765\u20131770 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012216_CR2","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 63, 3136\u20133141 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012216_CR3","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna, D.  et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. (Hoboken) 64, 1431\u20131446 (2012).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum2012216_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna, D.  et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. (Hoboken) 64, 1447\u20131461 (2012).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum2012216_CR5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang, W.  et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65, 1312\u20131324 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012216_CR6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan, K. M.  et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 46, 1372\u20131374 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012216_CR7","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung, S. I.  et al. HLA-B*5801 as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci.USA 102, 4134\u20134139 (2005).","journal-title":"Proc. Natl Acad. Sci.USA"},{"key":"BFnrrheum2012216_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2350-12-118","volume":"12","author":"R Somkrua","year":"2011","unstructured":"Somkrua, R., Eickmann, E. E., Soakaew, S., Lohitnavy, M. & Chaiyakunapruk, N. Association of HLA-B*5801 allele and allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrosis: a systematic review and meta-analysis. BMC Med. Genet. 12, 118 (2011).","journal-title":"BMC Med. Genet."},{"key":"BFnrrheum2012216_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub, R. A.  et al. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 62, 1060\u20131068 (2010).","journal-title":"Arthritis Rheum."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:30:56Z","timestamp":1684470656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2012.216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFnrrheum2012216"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2012.216","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}